On June 13, 2012, the research firm that MAPS has contracted to store the MDMA for use in our U.S. clinical studies notified MAPS that the shipment containing 937.14 grams of MDMA had safely arrived. The DEA approved the contractor’s Schedule I MDMA distributor’s license on April 23. Learn more…
